NO20033155L - Fremgangsmåte for hormonerstatningsterapi og dens administreringsform - Google Patents

Fremgangsmåte for hormonerstatningsterapi og dens administreringsform

Info

Publication number: NO20033155L
Authority: NO; Norway
Prior art keywords: administration; replacement therapy; hormone replacement; hormone; therapy
Prior art date: 2001-01-11

Application number

NO20033155A

Other languages

English (en)

Norwegian (no)

Other versions

NO20033155D0 (no

Inventor

Hermann Kulmann

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-11

Filing date

2003-07-10

Publication date

2003-09-10

2003-07-10 Application filed by Schering Ag filed Critical Schering Ag

2003-07-10 Publication of NO20033155D0 publication Critical patent/NO20033155D0/no

2003-09-10 Publication of NO20033155L publication Critical patent/NO20033155L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Investigating Or Analysing Biological Materials (AREA)

NO20033155A 2001-01-11 2003-07-10 Fremgangsmåte for hormonerstatningsterapi og dens administreringsform NO20033155L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10100911A DE10100911A1 (de)	2001-01-11	2001-01-11	Verfahren zur Hormonersatztherapie und dessen Darreichungsform
PCT/EP2002/000089 WO2002055086A2 (en)	2001-01-11	2002-01-08	Hormone replacement therapy method and its administration form

Publications (2)

Publication Number	Publication Date
NO20033155D0 NO20033155D0 (no)	2003-07-10
NO20033155L true NO20033155L (no)	2003-09-10

Family

ID=7670195

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20033155A NO20033155L (no)	2001-01-11	2003-07-10	Fremgangsmåte for hormonerstatningsterapi og dens administreringsform

Country Status (21)

Country	Link
US (1)	US7871994B2 (de)
EP (1)	EP1372665B1 (de)
JP (1)	JP2004525883A (de)
AR (1)	AR033413A1 (de)
AT (1)	ATE348620T1 (de)
AU (1)	AU2007202118A1 (de)
BR (1)	BR0206361A (de)
CA (1)	CA2433656A1 (de)
CY (1)	CY1106374T1 (de)
DE (2)	DE10100911A1 (de)
DK (1)	DK1372665T3 (de)
ES (1)	ES2278896T3 (de)
IL (1)	IL156655A0 (de)
MX (1)	MXPA03006157A (de)
NO (1)	NO20033155L (de)
NZ (1)	NZ539581A (de)
PE (1)	PE20020795A1 (de)
PT (1)	PT1372665E (de)
UY (1)	UY27117A1 (de)
WO (1)	WO2002055086A2 (de)
ZA (1)	ZA200306120B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003264203A1 (en) *	2002-08-28	2004-03-19	Robert Casper	Estrogen replacement regimen
WO2004041288A1 (en) *	2002-11-05	2004-05-21	Schering Aktiengesellschaft	Hormone replacement therapy with drospirenone
EP1558265B1 (de) *	2002-11-05	2010-01-06	Bayer Schering Pharma Aktiengesellschaft	Verwendung von drospirenon zur behandlung von hypertension
US7786101B2 (en)	2002-11-05	2010-08-31	Bayer Schering Pharma Ag	Cardiovascular protection using anti-aldosteronic progestins
EP1670440B1 (de)	2003-09-29	2014-04-30	Novo Nordisk Femcare AG	Hrt formulierungen
US8617597B2 (en)	2006-07-06	2013-12-31	Bayer Intellectual Property Gmbh	Pharmaceutical composition containing a tetrahydrofolic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4826831A (en) *	1983-08-05	1989-05-02	Pre Jay Holdings Limited	Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
DE4224534A1 (de)	1992-07-24	1994-01-27	Marika Dr Med Ehrlich	Ovulationshemmendes Mittel zur hormonalen Kontrazeption
DE4405590C1 (de)	1994-02-22	1995-07-20	Hesch Rolf Dieter Prof Dr Med	Mittel zur postmenopausalen Hormonbehandlung
DE4405591C1 (de)	1994-02-22	1995-07-20	Hesch Rolf Dieter Prof Dr Med	Mittel zur postmenopausalen Hormonsubstitution
DE19513662A1 (de) *	1995-04-08	1996-10-10	Schering Ag	Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19539233A1 (de)	1995-10-21	1997-04-24	Klaus Dr Med Umbreit	Oral einzunehmendes ovulationshemmendes Mittel

2001
- 2001-01-11 DE DE10100911A patent/DE10100911A1/de not_active Ceased
2002
- 2002-01-08 DK DK02700196T patent/DK1372665T3/da active
- 2002-01-08 BR BR0206361-1A patent/BR0206361A/pt not_active IP Right Cessation
- 2002-01-08 EP EP02700196A patent/EP1372665B1/de not_active Expired - Lifetime
- 2002-01-08 ES ES02700196T patent/ES2278896T3/es not_active Expired - Lifetime
- 2002-01-08 MX MXPA03006157A patent/MXPA03006157A/es unknown
- 2002-01-08 AT AT02700196T patent/ATE348620T1/de not_active IP Right Cessation
- 2002-01-08 DE DE60216899T patent/DE60216899T2/de not_active Expired - Lifetime
- 2002-01-08 PT PT02700196T patent/PT1372665E/pt unknown
- 2002-01-08 CA CA002433656A patent/CA2433656A1/en not_active Abandoned
- 2002-01-08 NZ NZ539581A patent/NZ539581A/en unknown
- 2002-01-08 JP JP2002555820A patent/JP2004525883A/ja active Pending
- 2002-01-08 IL IL15665502A patent/IL156655A0/xx unknown
- 2002-01-08 US US10/466,197 patent/US7871994B2/en not_active Expired - Fee Related
- 2002-01-08 WO PCT/EP2002/000089 patent/WO2002055086A2/en not_active Ceased
- 2002-01-09 UY UY27117A patent/UY27117A1/es not_active Application Discontinuation
- 2002-01-10 PE PE2002000009A patent/PE20020795A1/es not_active Application Discontinuation
- 2002-01-11 AR ARP020100080A patent/AR033413A1/es unknown
2003
- 2003-07-10 NO NO20033155A patent/NO20033155L/no not_active Application Discontinuation
- 2003-08-07 ZA ZA200306120A patent/ZA200306120B/en unknown
2007
- 2007-03-13 CY CY20071100350T patent/CY1106374T1/el unknown
- 2007-05-11 AU AU2007202118A patent/AU2007202118A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2433656A1 (en)	2002-07-18
DE60216899D1 (de)	2007-02-01
MXPA03006157A (es)	2003-09-16
US7871994B2 (en)	2011-01-18
ZA200306120B (en)	2004-09-08
EP1372665A2 (de)	2004-01-02
CY1106374T1 (el)	2011-10-12
ATE348620T1 (de)	2007-01-15
UY27117A1 (es)	2002-07-31
AR033413A1 (es)	2003-12-17
US20040106586A1 (en)	2004-06-03
EP1372665B1 (de)	2006-12-20
DE10100911A1 (de)	2002-08-01
JP2004525883A (ja)	2004-08-26
BR0206361A (pt)	2004-02-17
NO20033155D0 (no)	2003-07-10
PT1372665E (pt)	2007-03-30
PE20020795A1 (es)	2002-10-03
DK1372665T3 (da)	2007-04-30
ES2278896T3 (es)	2007-08-16
IL156655A0 (en)	2004-01-04
WO2002055086A3 (en)	2003-10-16
WO2002055086A2 (en)	2002-07-18
NZ539581A (en)	2007-07-27
DE60216899T2 (de)	2007-10-25
AU2007202118A1 (en)	2007-05-31

Publication	Publication Date	Title
FI20012017A0 (fi)	2001-10-17	Menetelmä ja laite magneettistimulaation annoslaskentaa varten
PL367272A1 (en)	2005-02-21	Novel substituted benzimidazole dosage forms and method of using same
NO20042993L (no)	2004-09-20	Formulering og doseringsform for kontrollert levering av terapeutiske midler
NO20050956L (no)	2005-04-27	Fremgangsmate og doseringsformer for kontrollert levering av paliperidon
AU2003297621A8 (en)	2004-06-23	Medical devices for delivery of therapeutic agents
AU1227302A (en)	2002-03-26	System and method for optimizing drug therapy for the treatment of diseases
EP1553899A4 (de)	2006-10-25	Verfahren und system für die intravesikuläre abgabe von therapeutischen mitteln
AU2003228436A1 (en)	2003-10-27	Method and apparatus for delivery of therapeutic agents
NO20042278D0 (no)	2004-06-02	Apparat og fremgangsmate for benkirurgi
EP1404343A4 (de)	2006-08-02	Therapeutische kombinationen zur behandlung von hormonmangelzuständen
IS7684A (is)	2005-02-03	Ný efnasambönd, blöndur og aðferðir til að meðhöndla bólgusjúkdóma og -ástand
IL160472A0 (en)	2004-07-25	Method and apparatus for treatment of patients
IL163725A0 (en)	2005-12-18	Administration of agents for the treatment of inflammation
NO20034097D0 (no)	2003-09-15	Hormonerstatningsterapi
FI20011403L (fi)	2002-12-30	Menetelmä ja koostumukset vatsan sairauksien hoitoon
NO20033854L (no)	2003-10-28	N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
SG116507A1 (en)	2005-11-28	Pharmaceutical dosage form and method of making.
NO20033123L (no)	2003-09-03	Terapeutisk hinne dannende sammensetning og behandlingsplan derav
NO20033506L (no)	2003-10-08	Parasitticidale preparater og metoder for anvendelse
NO20033155D0 (no)	2003-07-10	Fremgangsmate for hormonerstatningsterapi og dens administreringsform
FR2848817B1 (fr)	2005-09-09	Matelas therapeutique tricouches pour patients obeses
IS2331B (is)	2008-02-15	2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og meðferðarfræðileg notkun þeirra
GB0203518D0 (en)	2002-04-03	Wager administration system and method of operation thereof
AU2002351798A1 (en)	2003-05-12	Methods and dosage forms for improving the bioavailability of therapeutic agents
AU2002328905A1 (en)	2003-03-03	A method for determining the therapeutic effectiveness of a substance using a microphysiometer and use of the method

Legal Events

Date	Code	Title	Description
2009-08-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application